McKesson (MCK) came out with quarterly earnings of $6.18 per share, missing the Zacks Consensus Estimate of $6.34 per share. This compares to earnings of $7.19 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -2.52%. A quarter ago, it was expected that this prescription drug distributor would post earnings of $7.05 per share when it actually produced earnings of $7.74, delivering a surprise of 9.79%.Over the last four quarters, ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-13252 McKESSON CORPORATION (Exact name of registrant as specified in its charter) Delaware 94-3207296 (State or other jurisdiction ...

McKesson Corporation Fiscal 2024 Financial Results Fiscal 2025 Outlook May 7, 2024 Cautionary Statements Cautionary Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the ...

McKESSON CORPORATION REPORTS FISCAL 2024 FOURTH QUARTER AND FULL YEAR RESULTS Fourth Quarter Highlights: • Consolidated revenues of $76.4 billion increased by 11%. • Earnings per diluted share from continuing operations of $6.02 increased $0.31. • Adjusted Earnings per Diluted Share of $6.18 decreased by 14%. Full Year Highlights: • Consolidated revenues of $309.0 billion increased by 12%. • Earnings per diluted share from continuing operations of $22.39 decreased $2.66. • Adjusted Earnings per Diluted Shar ...

Wall Street analysts expect McKesson (MCK) to post quarterly earnings of $6.34 per share in its upcoming report, which indicates a year-over-year decline of 11.8%. Revenues are expected to be $78.72 billion, up 14.2% from the year-ago quarter.The consensus EPS estimate for the quarter has been revised 0.3% higher over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.Prior to a company's earnin ...

The market expects McKesson (MCK) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on May 7, 2024, might help the stock move higher if these key numbers are better th ...

McKesson (MCK) closed the latest trading day at $543.30, indicating a +0.62% change from the previous session's end. This change lagged the S&P 500's 1.02% gain on the day. Meanwhile, the Dow experienced a rise of 0.4%, and the technology-dominated Nasdaq saw an increase of 2.03%.The prescription drug distributor's stock has climbed by 0.58% in the past month, exceeding the Medical sector's loss of 5.2% and the S&P 500's loss of 3.15%.Investors will be eagerly watching for the performance of McKesson in its ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.Zacks Premium also includes the Zacks Style Scores.What are the Zacks Style Scores?Developed alon ...

McKessonCorporation (MCK) is well-poised for growth, backed by strategic collaborations and strength in the Distribution Solutions segment. However, the company’s opioid-related litigation expenses are a potential threat.Shares of this currently Zacks Rank #3 (Hold) company have risen 15.4% so far this year compared with the industry’s 6% growth. The S&P 500 Index has jumped 9.6% in the same time frame.McKesson is a healthcare services and information technology company with a market capitalization of $69.7 ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.Zacks Premium also includes the Zacks Style Scores.What a ...